FDA’s Megha Kaushal ASGCT talk: PFDD, patient voices, decision-making
Professor Paul Knoepfler, Ph.D.
I’ve been thinking more about the interplay between patient voices and FDA oversight of emerging cell and gene therapies. How do we find integration and balance here? In line with this topic, the FDA’s Megha Kaushal, MD spoke last week in Boston at ASGCT 2026 on patient voices. Kaushal is the Acting Deputy Director, Office […] The post FDA’s Megha Kaushal ASGCT talk: PFDD, patient voices, decision-making appeared first on The Niche .